Sanofi (France) To Pay MannKind Corporation Up To $925 Million For Inhaled Insulin

... activities. Under a separate supply agreement, MannKind will manufacture Afrezza at its manufacturing facility in Danbury, Connecticut. In addition, the companies are planning to collaborate to expand manufacturing capacity to meet global demand as ...



via Danbury Newswire http://ift.tt/1vxo8MF